01 FARMAK, a.s (1)
02 Alchymars ICM SM (1)
03 Alembic Pharmaceuticals Limited (2)
04 Apotex Pharmachem (2)
05 Bristol Myers Squibb (1)
06 Ipca Laboratories (2)
07 Napp Technologies (1)
08 Qilu Antibiotics Pharmaceutical Co., Ltd. (1)
09 Raks Pharma (1)
10 Taro Pharmaceutical Industries (1)
11 Teva API (1)
12 Unichem Laboratories Limited (1)
13 Venkata Narayana Active Ingredients (3)
14 Zydus Lifesciences (1)
01 WARFARIN POTASSIUM ISOPROPANOL SOLVATE (1)
02 WARFARIN SODIUM (1)
03 WARFARIN SODIUM (NON-STERILE, API) (1)
04 WARFARIN SODIUM AMORPHOUS USP (1)
05 WARFARIN SODIUM CLATHRATE (3)
06 WARFARIN SODIUM CLATHRATE USP (5)
07 WARFARIN SODIUM USP (4)
08 WARFARIN SODIUM USP (AMORPHOUS) (1)
09 WARFARIN SODIUM USP (CLATHRATE) (1)
10 WARFARIN SODIUM USP (CRYSTALLINE CLATHRATE) (1)
01 Canada (2)
02 China (1)
03 Czech Republic (1)
04 India (11)
05 Israel (1)
06 U.S.A (3)
01 Active (13)
02 Inactive (6)
01 Complete (2)
02 Blank (17)
89
PharmaCompass offers a list of Warfarin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Warfarin Sodium manufacturer or Warfarin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Warfarin Sodium manufacturer or Warfarin Sodium supplier.
PharmaCompass also assists you with knowing the Warfarin Sodium API Price utilized in the formulation of products. Warfarin Sodium API Price is not always fixed or binding as the Warfarin Sodium Price is obtained through a variety of data sources. The Warfarin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A MolPort-002-130-141 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-002-130-141, including repackagers and relabelers. The FDA regulates MolPort-002-130-141 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-002-130-141 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MolPort-002-130-141 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MolPort-002-130-141 supplier is an individual or a company that provides MolPort-002-130-141 active pharmaceutical ingredient (API) or MolPort-002-130-141 finished formulations upon request. The MolPort-002-130-141 suppliers may include MolPort-002-130-141 API manufacturers, exporters, distributors and traders.
click here to find a list of MolPort-002-130-141 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A MolPort-002-130-141 DMF (Drug Master File) is a document detailing the whole manufacturing process of MolPort-002-130-141 active pharmaceutical ingredient (API) in detail. Different forms of MolPort-002-130-141 DMFs exist exist since differing nations have different regulations, such as MolPort-002-130-141 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A MolPort-002-130-141 DMF submitted to regulatory agencies in the US is known as a USDMF. MolPort-002-130-141 USDMF includes data on MolPort-002-130-141's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MolPort-002-130-141 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of MolPort-002-130-141 suppliers with USDMF on PharmaCompass.
We have 14 companies offering MolPort-002-130-141
Get in contact with the supplier of your choice: